Yonekura, Kentaro, et al. “Cutaneous Adverse Reaction to Mogamulizumab May Indicate Favourable Prognosis in Adult T-Cell Leukaemia-Lymphoma”. Acta Dermato-Venereologica, vol. 96, no. 7, Apr. 2016, pp. 1000-2, doi:10.2340/00015555-2421.